SEARCH

SEARCH BY CITATION

Figure S1. Comparison of anti-MGO-apoB100 inhibition by pre-incubation of pooled plasma from type 2 diabetic patients with 100 μg mL−1 native or MGO-modified apoB100, human serum abumin (HSA), or human plasma fibronectin. Values are the mean of triplicate wells ± SD.

Figure S2. Scatter plot showing log CAC and normalized levels of IgM antibody against MGO-apoB100.

FilenameFormatSizeDescription
JOIM_2411_sm_FigS1-S2.doc239KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.